Terms: = Gastric cancer AND NFE2L2, ENSG00000116044, 4780, Q16236, NRF2 AND Prognosis
19 results:
1. B7-H3 confers stemness characteristics to gastric cancer cells by promoting glutathione metabolism through AKT/pAKT/nrf2 pathway.
Xia L; Chen Y; Li J; Wang J; Shen K; Zhao A; Jin H; Zhang G; Xi Q; Xia S; Shi T; Li R
Chin Med J (Engl); 2023 Aug; 136(16):1977-1989. PubMed ID: 37488673
[TBL] [Abstract] [Full Text] [Related]
2. FAM117B promotes gastric cancer growth and drug resistance by targeting the KEAP1/nrf2 signaling pathway.
Zhou Y; Chen Y; Shi Y; Wu L; Tan Y; Li T; Chen Y; Xia J; Hu R
J Clin Invest; 2023 Feb; 133(3):. PubMed ID: 36719368
[TBL] [Abstract] [Full Text] [Related]
3. Nuclear factor erythroid-2-related factor 2 (nrf2) is a potential prognostic factor in patients with gastric adenocarcinoma.
Alakuş H; Kaya M; Özer H; Eğilmez HR; Karadayı K
Arab J Gastroenterol; 2023 Feb; 24(1):5-10. PubMed ID: 36400701
[TBL] [Abstract] [Full Text] [Related]
4. Abnormal phenotype of nrf2 is associated with poor prognosis through hypoxic/VEGF-A-Rap1b/VEGFR2 pathway in gastric cancer.
Yang Y; Wang X; Zhang J; Gu H; Zhang S; Sun H; Liu J; Fan R
Aging (Albany NY); 2022 Apr; 14(7):3293-3312. PubMed ID: 35417854
[TBL] [Abstract] [Full Text] [Related]
5. Machine Learning Identifies Pan-cancer Landscape of nrf2 Oxidative Stress Response Pathway-Related Genes.
Li N; Zhan X
Oxid Med Cell Longev; 2022; 2022():8450087. PubMed ID: 35242279
[TBL] [Abstract] [Full Text] [Related]
6. Induction of ferroptosis by ATF3 elevation alleviates cisplatin resistance in gastric cancer by restraining nrf2/Keap1/xCT signaling.
Fu D; Wang C; Yu L; Yu R
Cell Mol Biol Lett; 2021 Jun; 26(1):26. PubMed ID: 34098867
[TBL] [Abstract] [Full Text] [Related]
7. Roles of nrf2 in gastric cancer: Targeting for Therapeutic Strategies.
Farkhondeh T; Pourbagher-Shahri AM; Azimi-Nezhad M; Forouzanfar F; Brockmueller A; Ashrafizadeh M; Talebi M; Shakibaei M; Samarghandian S
Molecules; 2021 May; 26(11):. PubMed ID: 34070502
[TBL] [Abstract] [Full Text] [Related]
8. sMicroRNA-28-5p acts as a metastasis suppressor in gastric cancer by targeting nrf2.
Yue CF; Li LS; Ai L; Deng JK; Guo YM
Exp Cell Res; 2021 May; 402(2):112553. PubMed ID: 33737068
[TBL] [Abstract] [Full Text] [Related]
9. A predictive model for assessing prognostic risks in gastric cancer patients using gene expression and methylation data.
Luo D; Yang Q; Wang H; Tan M; Zou Y; Liu J
BMC Med Genomics; 2021 Jan; 14(1):14. PubMed ID: 33407483
[TBL] [Abstract] [Full Text] [Related]
10. Pan-cancer Multiomics Analysis of TC2N Gene Suggests its Important Role(s) in Tumourigenesis of Many cancers.
Qureshi MA; Khan S; Tauheed MS; Syed SA; Ujjan ID; Lail A; Sharafat S
Asian Pac J Cancer Prev; 2020 Nov; 21(11):3199-3209. PubMed ID: 33247676
[TBL] [Abstract] [Full Text] [Related]
11. BDH2 triggers ROS-induced cell death and autophagy by promoting nrf2 ubiquitination in gastric cancer.
Liu JZ; Hu YL; Feng Y; Jiang Y; Guo YB; Liu YF; Chen X; Yang JL; Chen YY; Mao QS; Xue WJ
J Exp Clin Cancer Res; 2020 Jun; 39(1):123. PubMed ID: 32605589
[TBL] [Abstract] [Full Text] [Related]
12. TCF7L1 indicates prognosis and promotes proliferation through activation of Keap1/nrf2 in gastric cancer.
Zhang B; Wu J; Cai Y; Luo M; Wang B; Gu Y
Acta Biochim Biophys Sin (Shanghai); 2019 Apr; 51(4):375-385. PubMed ID: 30811526
[TBL] [Abstract] [Full Text] [Related]
13. Keratin 17 in disease pathogenesis: from cancer to dermatoses.
Yang L; Zhang S; Wang G
J Pathol; 2019 Feb; 247(2):158-165. PubMed ID: 30306595
[TBL] [Abstract] [Full Text] [Related]
14. Timing of chemotherapy-induced neutropenia is a prognostic factor in patients with advanced gastric cancer undergoing first-line chemotherapy with oxaliplatin and capecitabine: a retrospective study.
Wang Y; Chen Y; Yin H; Gu X; Shi Y; Dai G
Cancer Med; 2018 Apr; 7(4):997-1005. PubMed ID: 29532995
[TBL] [Abstract] [Full Text] [Related]
15. Combined Evaluation of Expression of CXCR4 and nrf2 as Prognostic Factor for Patients with gastric Carcinoma.
Yu S; Wu T; Wang J; Cheng C; Wang J; Sun L; Liu C; Cao G; Hu T
Anticancer Agents Med Chem; 2018; 18(3):388-393. PubMed ID: 29110625
[TBL] [Abstract] [Full Text] [Related]
16. RNA-binding motif protein 47 inhibits nrf2 activity to suppress tumor growth in lung adenocarcinoma.
Sakurai T; Isogaya K; Sakai S; Morikawa M; Morishita Y; Ehata S; Miyazono K; Koinuma D
Oncogene; 2016 Sep; 35(38):5000-9. PubMed ID: 26923328
[TBL] [Abstract] [Full Text] [Related]
17. Correlation Between Nuclear Factor E2-Related Factor 2 Expression and gastric cancer Progression.
Zheng H; Nong Z; Lu G
Med Sci Monit; 2015 Sep; 21():2893-9. PubMed ID: 26410168
[TBL] [Abstract] [Full Text] [Related]
18. Clinicopathological significance of nuclear factor (erythroid-2)-related factor 2 (nrf2) expression in gastric cancer.
Kawasaki Y; Ishigami S; Arigami T; Uenosono Y; Yanagita S; Uchikado Y; Kita Y; Nishizono Y; Okumura H; Nakajo A; Kijima Y; Maemura K; Natsugoe S
BMC Cancer; 2015 Jan; 15():5. PubMed ID: 25588809
[TBL] [Abstract] [Full Text] [Related]
19. nrf2 overexpression predicts prognosis and 5-FU resistance in gastric cancer.
Hu XF; Yao J; Gao SG; Wang XS; Peng XQ; Yang YT; Feng XS
Asian Pac J Cancer Prev; 2013; 14(9):5231-5. PubMed ID: 24175806
[TBL] [Abstract] [Full Text] [Related]
